Vita Advisors | Genomics

Posts Tagged “Genomics”

Show Commentary

2012 Potpourri XII

by Kevin Roche on Friday, April 6, 2012

An early spring for much of the country and our latest Potpourri is in full bloom, with nuggets on health information exchanges, genetic testing guidelines, an employer survey on reform, EMRs and lab test ordering and the relationship between clinical quality and patient satisfaction.

Tags: Genomics, Health Care Quality, Health Insurance, HIT, HITECH, Patient Satisfaction, Workplace

Personalized Medicine

by Kevin Roche on Wednesday, March 14, 2012

Years after it was initially predicted to do so, medical care based on individual genetic findings is becoming more pervasive. A new report from UnitedHealth Group examines trends and impacts over the next few years from this more personalized version of medicine.

Tags: Disease Management, Genomics, Health Care Costs, Health Care Quality

2011 Potpourri XXXV

by Kevin Roche on Friday, September 9, 2011

Fall looms and brings the football season. Our Potpourri scores with nutritious bites of health information, including getting more genetic data into medical records, giving doctors price lists, the value of HIEs, reducing hospital costs, medication continuation after hospitalization and use of episode-based payments.

Tags: Genomics, Health Care Costs, HIT, Hospital, Personalized Medicine, Physicians, Reimbursement

2011 Potpourri XI

by Kevin Roche on Friday, March 11, 2011

Another in our weekly series of health care nuggets, with this week’s Potpourri featuring Medicare beneficiaries and physician supply, the FDA’s position on certain device software, a wellness survey, the AMA’s stance on genetic testing, marketing of drugs, and an integrated disability and health care program.

Tags: Consumers, Drugs, FDA, Genomics, Health Care Quality, Medicare, Mobile, Physicians, Wellness and Prevention

Personalized Medicine Reimbursement

by Kevin Roche on Friday, December 10, 2010

Personalized medicine sometimes gets lost in the debate over other major health care issues, but it is probably the single most significant development in the actual delivery of medical care and will be so for the next decade. A new report details reimbursement hurdles to growth of the field.

Tags: Care Management, Genomics, Personalized Medicine, Regulation